RECURRENT TUBERCULOSIS NOTIFICATION AND TREATMENT RESULTS IN THE ARKHANGELSK REGION

The purpose of the investigation was to study trends in the prevalence of recurrent pulmonary tuberculosis and the efficiency of treatment in patients of this group from the civil sector of the Arkhangelsk Region in 2003 to 2009. There is evidence supporting that the epidemic situation has been rece...

Full description

Bibliographic Details
Main Authors: O. M. Mironyuk, E. I. Nikishova, E. V. Antusheva, A. O. Maryandyshev
Format: Article
Language:Russian
Published: NEW TERRA Publishing House 2014-01-01
Series:Tuberkulez i Bolezni Lëgkih
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/6
id doaj-cd732e4bb76d43eb92c8aeb0f4f0f41a
record_format Article
spelling doaj-cd732e4bb76d43eb92c8aeb0f4f0f41a2021-07-28T20:57:34ZrusNEW TERRA Publishing HouseTuberkulez i Bolezni Lëgkih2075-12302542-15062014-01-0101273310.21292/2075-1230-2014-0-1-27-336RECURRENT TUBERCULOSIS NOTIFICATION AND TREATMENT RESULTS IN THE ARKHANGELSK REGIONO. M. Mironyuk0E. I. Nikishova1E. V. Antusheva2A. O. Maryandyshev3Архангельский клинический противотуберкулезный диспансерАрхангельский клинический противотуберкулезный диспансерСеверный государственный медицинский университетСеверный государственный медицинский университетThe purpose of the investigation was to study trends in the prevalence of recurrent pulmonary tuberculosis and the efficiency of treatment in patients of this group from the civil sector of the Arkhangelsk Region in 2003 to 2009. There is evidence supporting that the epidemic situation has been recently improved, with the incidence of recurrent tuberculosis decreasing from 12.4 in 2003 to 7.8 per 100,000 population in 2009. There was a significant rise in the rates of multidrug-resistant tuberculosis among patients with its recurrences (29.2 and 32.5% in 2003 and 2009, respectively; p = 0.009542). Among the recurrent cases of the disease, the rate of bacteriological diagnosis verification increased from 16.3% in 2003 to 78.0% in 2009. Drug resistance in Mycobacterium tuberculosis among the recurrences remains high. Among the bacillary patients with recurrences, the proportion of those with multidrug-resistant tuberculosis was 55% in 2003 and 55.7% in 2009. There was one case of broad-spectrum drug resistance in the pathogen in 2005, 2007, and 2009. During the follow-up, the therapeutic efficiency decreased; this was due to the large number of cases who discontinued treatment for multidrug-resistant tuberculosis.https://www.tibl-journal.com/jour/article/view/6recurrent tuberculosistherapeutic efficiency
collection DOAJ
language Russian
format Article
sources DOAJ
author O. M. Mironyuk
E. I. Nikishova
E. V. Antusheva
A. O. Maryandyshev
spellingShingle O. M. Mironyuk
E. I. Nikishova
E. V. Antusheva
A. O. Maryandyshev
RECURRENT TUBERCULOSIS NOTIFICATION AND TREATMENT RESULTS IN THE ARKHANGELSK REGION
Tuberkulez i Bolezni Lëgkih
recurrent tuberculosis
therapeutic efficiency
author_facet O. M. Mironyuk
E. I. Nikishova
E. V. Antusheva
A. O. Maryandyshev
author_sort O. M. Mironyuk
title RECURRENT TUBERCULOSIS NOTIFICATION AND TREATMENT RESULTS IN THE ARKHANGELSK REGION
title_short RECURRENT TUBERCULOSIS NOTIFICATION AND TREATMENT RESULTS IN THE ARKHANGELSK REGION
title_full RECURRENT TUBERCULOSIS NOTIFICATION AND TREATMENT RESULTS IN THE ARKHANGELSK REGION
title_fullStr RECURRENT TUBERCULOSIS NOTIFICATION AND TREATMENT RESULTS IN THE ARKHANGELSK REGION
title_full_unstemmed RECURRENT TUBERCULOSIS NOTIFICATION AND TREATMENT RESULTS IN THE ARKHANGELSK REGION
title_sort recurrent tuberculosis notification and treatment results in the arkhangelsk region
publisher NEW TERRA Publishing House
series Tuberkulez i Bolezni Lëgkih
issn 2075-1230
2542-1506
publishDate 2014-01-01
description The purpose of the investigation was to study trends in the prevalence of recurrent pulmonary tuberculosis and the efficiency of treatment in patients of this group from the civil sector of the Arkhangelsk Region in 2003 to 2009. There is evidence supporting that the epidemic situation has been recently improved, with the incidence of recurrent tuberculosis decreasing from 12.4 in 2003 to 7.8 per 100,000 population in 2009. There was a significant rise in the rates of multidrug-resistant tuberculosis among patients with its recurrences (29.2 and 32.5% in 2003 and 2009, respectively; p = 0.009542). Among the recurrent cases of the disease, the rate of bacteriological diagnosis verification increased from 16.3% in 2003 to 78.0% in 2009. Drug resistance in Mycobacterium tuberculosis among the recurrences remains high. Among the bacillary patients with recurrences, the proportion of those with multidrug-resistant tuberculosis was 55% in 2003 and 55.7% in 2009. There was one case of broad-spectrum drug resistance in the pathogen in 2005, 2007, and 2009. During the follow-up, the therapeutic efficiency decreased; this was due to the large number of cases who discontinued treatment for multidrug-resistant tuberculosis.
topic recurrent tuberculosis
therapeutic efficiency
url https://www.tibl-journal.com/jour/article/view/6
work_keys_str_mv AT ommironyuk recurrenttuberculosisnotificationandtreatmentresultsinthearkhangelskregion
AT einikishova recurrenttuberculosisnotificationandtreatmentresultsinthearkhangelskregion
AT evantusheva recurrenttuberculosisnotificationandtreatmentresultsinthearkhangelskregion
AT aomaryandyshev recurrenttuberculosisnotificationandtreatmentresultsinthearkhangelskregion
_version_ 1721264451419635712